+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global 3D Printed Drugs (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

  • PDF Icon

    Report

  • 172 Pages
  • February 2024
  • Region: Global
  • Infogence Global Research
  • ID: 5503395
The Global 3D Printed Drugs Market is estimated to be USD 255.41 Mn in 2023 and is expected to reach USD 426.9 Mn by 2028 growing at a CAGR of 10.82%.

Market Dynamics

Market dynamics are forces that impact the prices and behaviors of the stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals.

As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.

Market Segmentations

  • The Global 3D Printed Drugs Market is segmented based on Drugs, Technology, Applications, End Users and Geography.
  • By Drugs, the market is classified into Spritam and Others.
  • By Technology, the market is classified into Direct-Write, Fused Deposition Modelling, Inkjet Printing, Powder Bed Printing, Stereolithography, and Zip Dose.
  • By Applications, the market is classified into Neurology, Orthopaedic, Hearing & Audibility Aid, Dental or Medical Implants, and Others.
  • By End Users, the market is classified into Hospitals, Clinics, and Research Laboratories.
  • By Geography, the market is classified into Americas, Europe, Middle East & Africa, and Asia-Pacific.

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are 3D Systems Inc., Anatomics Pty Ltd., Aprecia Pharmaceuticals LLC etc.

Countries Studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
  • Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

  • The report presents a detailed Ansoff matrix analysis for the Global 3D Printed Drugs Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.
  • The publisher analyses the Global 3D Printed Drugs Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
  • Based on the SWOT analysis conducted on the industry and industry players, the publisher has devised suitable strategies for market growth.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global 3D Printed Drugs Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth Market analysis using Porter's 5 forces model, PESTLE Analysis, and the Ansoff Matrix. In addition, the impact of COVID-19 and the impact of economic slowdown & impending recession on the Market are also featured in the Report
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains the competitive analysis using Positioning Quadrants, the Proprietary competitive positioning tool.

Report Highlights:

  • A complete analysis of the market, including parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size, Segmentations, and Outlook
4 Market Dynamics
4.1 Drivers
4.1.1 Rising Demand for Customized Drugs
4.1.2 Increasing Incidence of Chronic Diseases
4.2 Restraints
4.2.1 High Cost of 3D Printed Drugs
4.2.2 Government Strict Regulations for the Approval
4.3 Opportunities
4.3.1 Rapidly Growing R&D Activities in Healthcare Sector
4.3.2 Rising Advent of Technology such as 3D Printing
4.4 Challenges
4.4.1 Chances of Cyber Risk
4.4.2 Limited Availability of Raw Materials
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 PESTLE Analysis
5.4 Impact of COVID-19
5.5 Impact of Economic Slowdown & Impending Recession
5.6 Ansoff Matrix Analysis
6 Global 3D Printed Drugs Market, By Drugs
6.1 Introduction
6.2 Spritam
6.3 Others
7 Global 3D Printed Drugs Market, By Technology
7.1 Introduction
7.2 Direct-Write
7.3 Fused Deposition Modelling
7.4 Inkjet Printing
7.5 Powder Bed Printing
7.6 Stereolithography
7.7 Zip Dose
8 Global 3D Printed Drugs Market, By Applications
8.1 Introduction
8.2 Neurology
8.3 Orthopaedic
8.4 Hearing & Audibility Aid
8.5 Dental or Medical Implants
8.6 Others
9 Global 3D Printed Drugs Market, By End-Users
9.1 Introduction
9.2 Hospitals
9.3 Clinics
9.4 Research Laboratories
10 Americas' 3D Printed Drugs Market
10.1 Introduction
10.2 Argentina
10.3 Brazil
10.4 Canada
10.5 Chile
10.6 Colombia
10.7 Mexico
10.8 Peru
10.9 United States
10.10 Rest of Americas
11 Europe's 3D Printed Drugs Market
11.1 Introduction
11.2 Austria
11.3 Belgium
11.4 Denmark
11.5 Finland
11.6 France
11.7 Germany
11.8 Italy
11.9 Netherlands
11.10 Norway
11.11 Poland
11.12 Russia
11.13 Spain
11.14 Sweden
11.15 Switzerland
11.16 United Kingdom
11.17 Rest of Europe
12 Middle East and Africa's 3D Printed Drugs Market
12.1 Introduction
12.2 Egypt
12.3 Israel
12.4 Qatar
12.5 Saudi Arabia
12.6 South Africa
12.7 United Arab Emirates
12.8 Rest of MEA
13 APAC's 3D Printed Drugs Market
13.1 Introduction
13.2 Australia
13.3 Bangladesh
13.4 China
13.5 India
13.6 Indonesia
13.7 Japan
13.8 Malaysia
13.9 Philippines
13.10 Singapore
13.11 South Korea
13.12 Sri Lanka
13.13 Thailand
13.14 Taiwan
13.15 Rest of Asia-Pacific
14 Competitive Landscape
14.1 Competitive Quadrant
14.2 Market Share Analysis
14.3 Strategic Initiatives
14.3.1 M&A and Investments
14.3.2 Partnerships and Collaborations
14.3.3 Product Developments and Improvements
15 Company Profiles
15.1 3D Systems Inc.
15.2 Anatomics Pty Ltd.
15.3 Aprecia Pharmaceuticals LLC
15.4 BioDuro LLC
15.5 Biomedical Modelling Inc.
15.6 EnvisionTEC GmbH
15.7 FabRx Ltd.
15.8 General Electric Company
15.9 GlaxoSmithKline PLC
15.10 Hewlett Packard Caribe, BV LLC
15.11 Materialise NV
15.12 Merck KGaA
15.13 Nanalyze
15.14 Organovo Holdings, Inc.
15.15 Pharma Excipients International Ag.
15.16 PreScouter Inc.
15.17 Prodways Group SA
15.18 Renishaw PLC
15.19 Siemens Ag
15.20 SLM Solutions Group Ag
15.21 Stratasys Ltd.
15.22 Yissum Research Development Co.
15.23 Zortrax
16 Appendix
16.1 Questionnaire

Companies Mentioned

  • 3D Systems Inc.
  • Anatomics Pty Ltd.
  • Aprecia Pharmaceuticals LLC
  • BioDuro LLC
  • Biomedical Modelling Inc.
  • EnvisionTEC GmbH
  • FabRx Ltd.
  • General Electric Company
  • GlaxoSmithKline PLC
  • Hewlett Packard Caribe, BV LLC
  • Materialise NV
  • Merck KGaA
  • Nanalyze
  • Organovo Holdings, Inc.
  • Pharma Excipients International Ag.
  • PreScouter Inc.
  • Prodways Group SA
  • Renishaw PLC
  • Siemens Ag
  • SLM Solutions Group Ag
  • Stratasys Ltd.
  • Yissum Research Development Co.
  • Zortrax

Table Information